Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Anaesthesia for electroconvulsive therapy - new tricks for old drugs: a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Great boast, small roast on effects of selective serotonin reuptake inhibitors: response to a critique of our systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. No effect of escitalopram versus placebo on brain-derived neurotrophic factor in healthy individuals: a randomised trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Acupuncture for chronic hepatitis B

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis

    Research output: Contribution to journalReviewResearchpeer-review

  4. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

In this response, we address point by point the additional issues raised by Hieronymus et al. in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. We repulse that we are biased or mistaken in any major ways. We acknowledge that we missed a few small, mostly unpublished trials, and we made a few minor errors in our systematic review. However, these omissions and errors neither have any impact on our overall results nor on our conclusions. The critique by Hieronymus et al.seem to raise questions about their understanding of the systematic review process and, on several occasions, they wrongly claimed that we made errors. Our analyses should be impartial and free from any biases or prejudices as we do not have any obligation to support the interests of sponsors or other groups.

Original languageEnglish
JournalActa Neuropsychiatrica
Pages (from-to)1-28
Number of pages28
ISSN1601-5215
DOIs
Publication statusE-pub ahead of print - 24 Jun 2019

ID: 57627000